Cite
In Situ Tumor Vaccine Expressing Anti-CD47 Antibody Enhances Antitumor Immunity.
MLA
Zhang, Bin, et al. “In Situ Tumor Vaccine Expressing Anti-CD47 Antibody Enhances Antitumor Immunity.” Frontiers in Oncology, vol. 12, June 2022, pp. 1–13. EBSCOhost, https://doi.org/10.3389/fonc.2022.897561.
APA
Zhang, B., Shu, Y., Hu, S., Qi, Z., Chen, Y., Ma, J., Wang, Y., & Cheng, P. (2022). In Situ Tumor Vaccine Expressing Anti-CD47 Antibody Enhances Antitumor Immunity. Frontiers in Oncology, 12, 1–13. https://doi.org/10.3389/fonc.2022.897561
Chicago
Zhang, Bin, Yongheng Shu, Shichuan Hu, Zhongbing Qi, Yanwei Chen, Jinhu Ma, Yunmeng Wang, and Ping Cheng. 2022. “In Situ Tumor Vaccine Expressing Anti-CD47 Antibody Enhances Antitumor Immunity.” Frontiers in Oncology 12 (June): 1–13. doi:10.3389/fonc.2022.897561.